Bedaquiline in Tuberculosis and Cancer: Energy Metabolism as
2026-08-02
Explore how Bedaquiline, a diarylquinoline antibiotic, disrupts energy metabolism in both Mycobacterium tuberculosis and cancer stem cells. This in-depth analysis uniquely links mitochondrial targeting to practical assay decisions for multi-drug resistant tuberculosis treatment and cancer research.
Pleiotrophin’s Role in Prostate Hyperplasia: Mechanisms and
2026-08-01
Liu et al. reveal pleiotrophin (PTN) as a critical regulator of benign prostatic hyperplasia (BPH), linking its expression to cell proliferation, contraction, and fibrosis in the prostate. Their integrative approach uncovers PTN’s modulation of the AKT and RhoA/ROCK1/2 pathways, advancing the understanding of BPH pathogenesis and highlighting new avenues for targeted intervention.
10058-F4 C-Myc-Max Dimerization Inhibitor: Workflows & Insig
2026-07-31
10058-F4 streamlines c-Myc transcription factor inhibition for apoptosis and oncogenic pathway studies in leukemia and prostate cancer models. This article details robust experimental workflows, troubleshooting strategies, and how new discoveries in telomerase regulation can guide advanced assay design.
TAI-1 Hec1 Inhibitor: Elevating Cancer Research Workflows
2026-07-31
TAI-1, a potent Hec1 inhibitor from APExBIO, delivers a leap in targeted apoptotic induction and cancer cell proliferation inhibition—demonstrating 1,000-fold potency over previous tools. Its robust mitotic disruption, synergy with chemotherapies, and selective toxicity profile set a new standard for translational and preclinical oncology workflows.
Ciclesonide and the Future of Targeted Protein Degradation i
2026-07-30
Explore how mechanistic insights into Ciclesonide's prodrug activation and glucocorticoid receptor binding, coupled with advances in ERAD-hijacking technologies, are reshaping translational respiratory research. This article offers a strategic guide for researchers seeking to harness next-generation anti-inflammatory agents in asthma and allergic rhinitis studies, while highlighting APExBIO Ciclesonide as a pivotal tool for experimental excellence.
Biotin-HPDP: Optimizing Thiol-Specific Protein Labeling Work
2026-07-30
Biotin-HPDP (N-[6-(biotinamido)hexyl]-3’-(2’-pyridyldithio)propionamide) offers reversible, high-sensitivity thiol-specific protein labeling, streamlining detection of redox modifications and affinity purification. This guide details practical workflows, troubleshooting strategies, and innovations from recent Alzheimer’s disease research, showing how to harness APExBIO’s reagent for robust and reproducible results.
Diterpene JXE-23 Triggers Autophagy and G2/M Arrest in HCC C
2026-07-29
This study identifies ent-8(14),15-pimaradiene-2β,19-diol (JXE-23), a diterpene from Aleuritopteris albofusca, as a selective inhibitor of hepatocellular carcinoma (HCC) cell growth. JXE-23 induces G2/M cell cycle arrest and protective autophagy, highlighting a promising direction for anticancer drug research and combination strategies targeting autophagy.
Grazoprevir Hydrate: Precision Targeting of HCV Replication
2026-07-29
Explore the advanced antiviral mechanisms of Grazoprevir hydrate in hepatitis C virus replication inhibition, with a deep dive into pharmacodynamics, clinical impact, and protocol optimization. Discover insights that extend beyond standard workflows.
Enhanced Lysosomal Exocytosis Drives Cartilage Pathology in
2026-07-28
This study demonstrates that enhanced lysosomal exocytosis and disrupted growth factor signaling are central to cartilage pathology in a zebrafish model of mucopolysaccharidosis type IVA (MPS IVA). By connecting exocytosis dynamics with altered protease activity and signaling, the findings expand the mechanistic landscape of lysosomal storage disorders and highlight new experimental strategies for probing skeletal disease.
SM-102-Enabled mRNA Delivery: Protocols and Practical Insigh
2026-07-28
SM-102 is revolutionizing mRNA vaccine delivery systems, enabling precise and efficient lipid nanoparticle (LNP) formulation for both therapeutic and immunization applications. This article distills validated experimental protocols, advanced troubleshooting, and real-world case studies—including localized tumor suppressor therapy—empowering researchers to maximize the translational impact of SM-102.
HSP70 Modulates Poly-PR–Induced TDP-43 Condensation in ALS M
2026-07-27
Agnihotri et al. (2025) elucidate how C9ORF72 poly-PR dipeptides drive NEAT1-dependent TDP-43 nuclear condensation and reveal HSP70 as a critical regulator of condensate fluidity. These findings clarify molecular events underlying ALS-linked proteinopathy and provide a mechanistic basis for targeting Hsp70 in neurodegenerative disease research.
Ferulic Acid Targets ER Stress to Counter Chemotherapy-Induc
2026-07-27
This study demonstrates that ferulic acid alleviates chemotherapy-induced premature ovarian insufficiency (POI) in mice by attenuating endoplasmic reticulum (ER) stress and apoptosis in granulosa cells. The findings provide mechanistic insight into ER stress pathways in POI and present ferulic acid as a promising candidate for ovarian protection.
Pcbp1 Regulates Mitochondrial Integrity and Antibody Product
2026-07-26
This study uncovers the pivotal role of the RNA-binding protein Pcbp1 in maintaining mitochondrial function to support antibody production and germinal center responses in B cells. The findings illuminate how posttranscriptional regulation links mitochondrial electron transport chain integrity to adaptive immunity, offering mechanistic insights for immunology and cell biology research.
Gamma-linolenic Acid: Applied Workflows for Inflammation Res
2026-07-25
Gamma-linolenic acid (GLA) is a versatile tool in anti-inflammatory and cell-based research, offering clear advantages in assay reproducibility and mechanistic modeling. This article translates cutting-edge immunology findings into actionable protocols, troubleshooting, and advanced applications with APExBIO’s GLA (C5518).
Flubendazole in Autophagy Modulation: Protocols and Innovati
2026-07-24
Flubendazole (methyl N-[6-(4-fluorobenzoyl)-1H-benzimidazol-2-yl]carbamate) redefines autophagy modulation research by streamlining workflows across cancer biology and neurodegenerative disease models. Discover evidence-driven protocols, troubleshooting insights, and unique comparative advantages for robust, reproducible autophagy signaling assays.
462 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page